Analysis toolkit for evaluation of drug titration practice in acute lymphoblastic leukemia maintenance.
During the 2-year maintenance treatment phase (MT) of acute lymphoblastic leukemia (ALL), personalized patient-specified titration of oral antimetabolite drug doses is required to ensure maximum tolerated systemic drug exposure. Drug titration is difficult to implement in practice and insufficient systemic drug exposure resulting from inadequate dose titration increases risk of ALL relapse.
Author(s): Mungle, Tushar, Mahadevan, Ananya, Mukhopadhyay, Jayanta, Bhattacharya, Sangeeta Das, Saha, Vaskar, Krishnan, Shekhar
DOI: 10.1093/jamiaopen/ooae089